Assignee
NABI BIOPHARMACEUTICALS
US·12 granted patents·9 pending applications·166 citations·filing 1999–2011
Top patents by PatentIndex Score
21 records- 0193US7247502B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2004·Granted Jul 24, 2007·41 cites·2 claims
- 0291US7776620B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2007·Granted Aug 17, 2010·12 cites·5 claims
- 0391US7446205B2Method for making nicotine haptenNABI BIOPHARMACEUTICALS·Filed 2006·Granted Nov 4, 2008·11 cites·15 claims
- 0488US7449189B2Glycoconjugate vaccines for use in immune-compromised populationsNABI BIOPHARMACEUTICALS·Filed 2006·Granted Nov 11, 2008·4 cites·18 claims
- 0588US7030101B2Compositions of β-glucans and specific antibodiesNABI BIOPHARMACEUTICALS·Filed 2002·Granted Apr 18, 2006·24 cites·24 claims
- 0686US7547712B2Methods for decreasing the toxic effects of nicotine on fetuses in pregnant womenNABI BIOPHARMACEUTICALS·Filed 2007·Granted Jun 16, 2009·10 cites·20 claims
- 0783US6875445B2Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorptionNABI BIOPHARMACEUTICALS·Filed 2002·Granted Apr 5, 2005·18 cites·36 claims
- 0877US8026109B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2010·Granted Sep 27, 2011·2 cites·3 claims
- 0977US6773891B2Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2002·Granted Aug 10, 2004·6 cites·2 claims
- 1076US6936258B1Staphylococcus antigen and vaccineNABI BIOPHARMACEUTICALS·Filed 1999·Granted Aug 30, 2005·33 cites·18 claims
- 1171US7531633B2Staphylococcus antibodiesNABI BIOPHARMACEUTICALS·Filed 2004·Granted May 12, 2009·4 cites·13 claims
- 1266US7291343B2Enterococcus antigens and vaccinesNABI BIOPHARMACEUTICALS·Filed 2004·Granted Nov 6, 2007·1 cites·24 claims
- 1358US2011217320A1Hapten-carrier conjugates for treating and preventing nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2011·Application pending·0 cites
- 1454US2006134141A1Glycoconjugate vaccines containing peptidoglycanNABI BIOPHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 1553US2006153857A1Method of treating staphylococcus aureus infectionNABI BIOPHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 1647US2009053235A1Use of alpha-toxin for treating and preventing staphylococcus infectionsNABI BIOPHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 1747US2008131457A1Use of alpha-toxin for treating and preventing staphylococcus infectionsNABI BIOPHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 1845US2006228368A1Method of protecting against staphylococcal infectionNABI BIOPHARMACEUTICALS·Filed 2005·Application pending·0 cites
- 1941US2011064750A1Method and kit for treating nicotine addictionNABI BIOPHARMACEUTICALS·Filed 2010·Application pending·0 cites
- 2037US2009074755A1Use of panton-valentine leukocidin for treating and preventing staphylococcus infectionsNABI BIOPHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 2136US2011182918A1Personalized drug treatment and smoking cessation kit and methodNABI BIOPHARMACEUTICALS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NABI BIOPHARMACEUTICALS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →